ASKA to Accelerate Innovative Pharma Biz, Not Generics; President Sees Trivial Impact from Follow-On Blopress AG

ASKA President Sota Yamaguchi ASKA Pharmaceutical is poised to speed up its innovative pharma business revolving around women’s health and won’t plow heavy money into generics, President Sota Yamaguchi, who took over the company’s reins in June, tells Jiho. ASKA...read more